| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/02/2006 | EP1684624A2 Human prostate cancer cell factor(s) that induce stem cell commitment and osteogenesis |
| 08/02/2006 | EP1395242B1 Liquid pharmaceutical composition |
| 08/02/2006 | EP1276485B1 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 08/02/2006 | EP1263418B1 Method of preparing cartilage enhancing food supplements |
| 08/02/2006 | EP1239791B1 Dental prosthesis with means for the release of active substances |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1165137B1 Sphingomyelin containing preparation for the enhancement of tumor therapy |
| 08/02/2006 | EP1163274B1 Process for cross-linking hyaluronic acid to polymers |
| 08/02/2006 | EP1133476B1 Iminoguanidine derivatives, preparation method, use as medicines |
| 08/02/2006 | EP1107974B1 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
| 08/02/2006 | CN2801159Y Powder medicine patch packaged by immediate dissolution film |
| 08/02/2006 | CN1812981A Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 08/02/2006 | CN1812974A N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812824A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/02/2006 | CN1810289A Compounding process of scorpion medicine wine |
| 08/02/2006 | CN1810286A Externally applied plaster |
| 08/02/2006 | CN1810280A Medicine composition for treating rheumatism, rheumatoidal diseases, etc. and its prepn process |
| 08/02/2006 | CN1810278A Enteric coated Chinese medicine composition for treating cervical and lumbar spondylopathy |
| 08/02/2006 | CN1810238A Oral arginine prepn for preventing and treating cachexia syndrome |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/02/2006 | CN1267408C Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267139C Medicinal ointment for bone injury |
| 08/02/2006 | CN1267129C Red plaster for bone spur and its preparing method |
| 08/02/2006 | CN1267127C Osteoproliferation medicine for external application |
| 08/02/2006 | CN1267117C Chinese medicine composition for curing traumatic injury and pains in chest and hypochondrium and its preparing method |
| 08/02/2006 | CN1267113C Extract of mulberry twig and its extracting process and novel usage |
| 08/02/2006 | CN1267107C Extraction method of scorpion active protein liquid |
| 08/01/2006 | US7084167 A secondary aminemethyl-indole derivatives, for treating diseases or physiological disorders; calcimimetic activity |
| 08/01/2006 | US7084161 Method for treating inflammatory diseases or conditions |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084156 2-Aminoquinoline compounds |
| 08/01/2006 | US7084151 Urogenital disorders; dysmenorrhea; endometriosis; anticancer agents |
| 08/01/2006 | US7084147 Anilinoquinazaolines as protein tyrosine kinase inhibitors |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 08/01/2006 | US7084123 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/01/2006 | US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents |
| 08/01/2006 | US7084121 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7084108 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083820 Dehydration and stabilization of naturally occurring substance containing biologically active components, e.g. proteins, by heating with a microbiocide at a temperature below denaturization; food processing; drugs; cosmetics |
| 08/01/2006 | CA2395623C Inulin products with improved nutritional properties |
| 08/01/2006 | CA2338214C Heterocyclic compounds as inhibitors of rotamase enzymes |
| 08/01/2006 | CA2255668C Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use |
| 08/01/2006 | CA2234611C New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 08/01/2006 | CA2192456C Pyridylbisphosphonates for use as a therapeutical agent |
| 07/27/2006 | WO2006078211A1 Growth factor composition |
| 07/27/2006 | WO2006078120A1 Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis |
| 07/27/2006 | WO2006077013A1 Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases |
| 07/27/2006 | WO2006076844A1 Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof |
| 07/27/2006 | WO2006029275A3 Methods of using death receptor ligands and cd20 antibodies |
| 07/27/2006 | WO2005110480A3 Combination of organic compounds |
| 07/27/2006 | US20060168667 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 07/27/2006 | US20060167483 Method, instruments, and kit for autologous transplantation |
| 07/27/2006 | US20060167261 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167083 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
| 07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |
| 07/27/2006 | US20060167049 Terphenly derivatives, preparation thereof, compositions containing same |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060167034 Novel benzonaphthyridines |
| 07/27/2006 | US20060167014 Piperazine compounds and medicinal use thereof |
| 07/27/2006 | US20060167007 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 07/27/2006 | US20060167003 Probucol derivatives |
| 07/27/2006 | US20060167001 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2006 | US20060166988 Novel compounds |
| 07/27/2006 | US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 07/27/2006 | US20060166966 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |
| 07/27/2006 | US20060166938 Method of treatment using bisphosphonic acid |
| 07/27/2006 | US20060166927 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 07/27/2006 | US20060166899 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 07/27/2006 | US20060166890 Non-t cell binding peptides and their uses |
| 07/27/2006 | US20060165821 Composition comprising scutellaria baicalensis and their uses thereof |
| 07/27/2006 | US20060165778 Enteric composition for the manufacture of soft capsule wall |
| 07/27/2006 | US20060165733 Liquid formulations with high concentration of hunan growth hormone (hgh) comprising phenol |
| 07/27/2006 | US20060165696 Remedy for spinal injury containing interleukin-6 antagonist |
| 07/27/2006 | US20060165683 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 07/27/2006 | US20060165678 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 07/27/2006 | US20060165675 Modulation of mesenchymal cells via iga-receptors |
| 07/27/2006 | DE102005002500A1 Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen Tetrahydrofuran derivatives as inhibitors of matrix metalloproteinases |
| 07/27/2006 | CA2601357A1 Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases |
| 07/27/2006 | CA2593561A1 Combining therapies targeting multiple toll-like receptors and use thereof |
| 07/26/2006 | EP1683786A1 Vitamin d3 lactam derivative |
| 07/26/2006 | EP1682546A1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates |
| 07/26/2006 | EP1682532A1 Pyrimidines as inhibitors of phosphoinositide-3-kinases (pi3k) |
| 07/26/2006 | EP1682226A1 A lipid preparation for enhancing mineral absorption |
| 07/26/2006 | EP1682150A2 Compositions and methods for inducing cell dedifferentiation |